Mechanism that aggravates metabolic fatty liver disease discovered
An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent metabolic fatty liver disease from progressing toward more serious conditions, such as cirrhosis or liver cancer.This article was […]
